Claire Entwisle

677 total citations
21 papers, 550 citations indexed

About

Claire Entwisle is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Claire Entwisle has authored 21 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Claire Entwisle's work include Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (5 papers) and Pneumonia and Respiratory Infections (5 papers). Claire Entwisle is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (5 papers) and Pneumonia and Respiratory Infections (5 papers). Claire Entwisle collaborates with scholars based in United Kingdom, United States and Australia. Claire Entwisle's co-authors include C. S. McLean, M. E. G. Boursnell, Stephen Inglis, D M Blakeley, Imogen Duncan, R. Jennings, Robert C. Rees, Claudia Roberts, Gilly Martin and Susan E. Chisholm and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Immunology.

In The Last Decade

Claire Entwisle

20 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Entwisle United Kingdom 12 256 188 139 138 92 21 550
Vladimı́r Vonka Czechia 19 552 2.2× 297 1.6× 198 1.4× 175 1.3× 247 2.7× 58 920
Viviane Bechtold Belgium 9 202 0.8× 221 1.2× 158 1.1× 50 0.4× 63 0.7× 11 457
Michelle L. Paulson United States 8 259 1.0× 822 4.4× 150 1.1× 147 1.1× 105 1.1× 11 1.1k
Marie-Claude Trescol-Biémont France 14 366 1.4× 384 2.0× 146 1.1× 88 0.6× 218 2.4× 20 805
Floriane Auderset Switzerland 16 245 1.0× 586 3.1× 182 1.3× 47 0.3× 63 0.7× 20 931
Jean Publicover United States 16 435 1.7× 456 2.4× 171 1.2× 167 1.2× 148 1.6× 18 1.1k
Marie J. Estcourt Australia 13 227 0.9× 617 3.3× 228 1.6× 97 0.7× 197 2.1× 25 927
Darlene Marti United States 14 486 1.9× 467 2.5× 89 0.6× 44 0.3× 78 0.8× 18 1.0k
Gary A. Waanders Switzerland 19 137 0.5× 1.0k 5.3× 198 1.4× 236 1.7× 170 1.8× 27 1.2k
Jörg Reimann Germany 15 177 0.7× 466 2.5× 125 0.9× 117 0.8× 57 0.6× 27 646

Countries citing papers authored by Claire Entwisle

Since Specialization
Citations

This map shows the geographic impact of Claire Entwisle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Entwisle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Entwisle more than expected).

Fields of papers citing papers by Claire Entwisle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Entwisle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Entwisle. The network helps show where Claire Entwisle may publish in the future.

Co-authorship network of co-authors of Claire Entwisle

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Entwisle. A scholar is included among the top collaborators of Claire Entwisle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Entwisle. Claire Entwisle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Entwisle, Claire, Giuseppe Ercoli, Ann McIlgorm, et al.. (2022). Corrected and Republished from: “A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against LethalStreptococcus pneumoniaeChallenge”. Infection and Immunity. 90(1). e0084618a–e0084618a. 4 indexed citations
2.
Entwisle, Claire, Ann McIlgorm, Polly Burbidge, et al.. (2018). Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae. Vaccine. 36(29). 4255–4264. 10 indexed citations
3.
Entwisle, Claire, Giuseppe Ercoli, Elisa Ramos‐Sevillano, et al.. (2018). A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against LethalStreptococcus pneumoniaeChallenge. Infection and Immunity. 87(3). 25 indexed citations
4.
Entwisle, Claire, et al.. (2017). Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A Phase 1 randomised clinical trial. Vaccine. 35(51). 7181–7186. 35 indexed citations
5.
Colaço, Camilo, Claire Entwisle, Sue Hill, et al.. (2015). Next Generation Vaccines: Development of a Novel Streptococcus pneumoniae Multivalent Protein Vaccine. BioProcessing Journal. 14(3). 9 indexed citations
6.
Chionh, Yok Teng, Garrett Z. Ng, Claire Entwisle, et al.. (2014). Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant. Vaccine. 32(20). 2350–2358. 20 indexed citations
7.
Lau, Eduardo C., et al.. (2013). An ultra scale‐down characterization of low shear stress primary recovery stages to enhance selectivity of fusion protein recovery from its molecular variants. Biotechnology and Bioengineering. 110(7). 1973–1983. 13 indexed citations
8.
Ahmad, Murrium, Robert C. Rees, Stéphanie McArdle, et al.. (2005). Regulation of CTL responses to MHC‐restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC–mGM‐CSF. International Journal of Cancer. 115(6). 951–959. 7 indexed citations
9.
Ali, Selman, Murrium Ahmad, C. S. McLean, et al.. (2004). Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine. 22(27-28). 3585–3594. 43 indexed citations
10.
Lucas, Michaela, Eliza Tsitoura, María Montoya, et al.. (2003). Characterization of secreted and intracellular forms of a truncated hepatitis C virus E2 protein expressed by a recombinant herpes simplex virus. Journal of General Virology. 84(3). 545–554. 10 indexed citations
12.
Morris, Arden M., et al.. (2001). Induction of Anti-Mammary Cancer Immunity by Engaging the OX-40 Receptor in Vivo. Breast Cancer Research and Treatment. 67(1). 71–80. 56 indexed citations
13.
McLean, C. S., M. E. G. Boursnell, G Martín, et al.. (2000). Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.. PubMed. 60(6). 1663–70. 31 indexed citations
14.
Kim, Se‐Heon, John F. Carew, David A. Kooby, et al.. (2000). Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Therapy. 7(9). 1279–1285. 18 indexed citations
15.
Boursnell, M. E. G., Claire Entwisle, Shiva Sivasubramaniam, et al.. (1998). Disabled Infectious Single Cycle (DISC) Herpes Simplex Virus as a Vector for Immunotherapy of Cancer. Advances in experimental medicine and biology. 451. 379–384. 10 indexed citations
16.
Zhang, Xiaoliu, Stephen Inglis, M. E. G. Boursnell, et al.. (1998). An efficient selection system for packaging herpes simplex virus amplicons.. Journal of General Virology. 79(1). 125–131. 20 indexed citations
17.
Boursnell, M. E. G., Claire Entwisle, D M Blakeley, et al.. (1997). A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease. The Journal of Infectious Diseases. 175(1). 16–25. 135 indexed citations
18.
Entwisle, Claire, et al.. (1993). Purification and characterisation of recombinant murine interleukin-5 glycoprotein, from a Baculovirus expression system. Biochemical Society Transactions. 21(4). 332S–332S.
19.
Dodd, Ian B., et al.. (1993). Susceptibility of mutant, recombinant plasminogen activators to proteolytic breakdown: Removal of the F domain by plasmin. Fibrinolysis and Proteolysis. 7(4). 237–241. 1 indexed citations
20.
Robinson, J.H., Molly Browne, J.E. Carey, et al.. (1992). A recombinant, chimeric enzyme with a novel mechanism of action leading to greater potency and selectivity than tissue-type plasminogen activator.. Circulation. 86(2). 548–552. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026